Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001638599-20-000842

Director bought 1,578,947 shares at $19.00 ($29,999,993)

  • Director acquired 8,332,778 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +329,478 350,169 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +2,965,263 3,151,483 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +370,552 720,721 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +4,047,634 7,199,117 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +45,524 766,245 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion +574,327 7,773,444 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Purchase +104,628 $19.00 $1,987,932 870,873 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Purchase +1,474,319 $19.00 $28,012,061 9,247,763 I
Derivatives
BAKER BROS. ADVISORS LP Director 2020-03-27 Purchase · Series B Preferred Stock +308,793 $3.93 $1,214,298 308,793 I
BAKER BROS. ADVISORS LP Director 2020-03-27 Purchase · Series B Preferred Stock +3,373,029 $3.93 $13,264,099 3,373,029 I
BAKER BROS. ADVISORS LP Director 2020-08-21 Purchase · Series C Preferred Stock +75,873 $14.52 $1,101,646 75,873 I
BAKER BROS. ADVISORS LP Director 2020-08-21 Purchase · Series C Preferred Stock +957,211 $14.52 $13,898,321 957,211 I
BAKER BROS. ADVISORS LP Director 2020-09-24 Grant or award · Non-Qualified Stock Option (right to buy) +46,688 46,688 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series A Convertible Preferred Stock −329,478 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series A Convertible Preferred Stock −2,965,263 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series A Convertible Preferred Stock −219,653 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +219,653 219,653 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series A Convertible Preferred Stock −1,976,841 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +1,976,841 1,976,841 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series B Convertible Preferred Stock −370,552 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series B Convertible Preferred Stock −4,047,634 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series B Convertible Preferred Stock −247,034 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +247,034 466,687 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series B Convertible Preferred Stock −2,698,424 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +2,698,424 4,675,265 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series C Convertible Preferred Stock −45,524 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series C Convertible Preferred Stock −574,327 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series C Convertible Preferred Stock −30,349 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +30,349 497,036 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Series C Convertible Preferred Stock −382,884 0 I
BAKER BROS. ADVISORS LP Director 2020-09-29 Conversion · Non-Voting Common Stock +382,884 5,058,149 I
Open-market purchases · 1,578,947 sh · avg $19.00 · $29,999,993
Loading xslF345X03/doc4_6886.xml…